Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06001697 · ClinicalTrials.gov registry record · NA
Nature and Health: How Does Lifestyle and Environment Affect Health and Wellness
A NA study of Depression and Anxiety, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 134
- Enrollment target
- 1
- Study location
NCT06001697: Completed NA study of Depression and Anxiety, sponsored by Stanford University.
NCT06001697 is a NA study of Depression and Anxiety that has completed, run by Stanford University. The registered enrollment target is 134 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06001697, a NA study of Depression and Anxiety, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 134 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to examine if and how implementing nature prescriptions can increase time in nature and improve health to yield an actionable understanding of the nature-health connection. It aims to explore how public green spaces can be better used to improve individual and community health. Finally, this study aims to advance science by conducting a randomized controlled trial to improve understanding of the linkages between time in nature and human health.
Primary Outcome
Assess each participant's exposure to nature in everyday life. The Nature Exposure Scale II uses a 5-point likert scale for each item. Higher score means greater exposure to nature. The total score is an average of all the items included.
Conditions Studied
Interventions
- BEHAVIORAL Park prescription
- BEHAVIORAL Regular health advice
Study Locations (1)
Pennsylvania
- Forbes Family Medicine/AHN Research Institute - Monroeville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 134 participants |
| Start Date | 2023-12-18 |
| Est. Completion | 2025-04-23 |
| Phase | NA |
What the finished NCT06001697 record still lists
NCT06001697 is an interventional study that assigns participants to a tested intervention. The registered 134 participants enrollment target is mid-sized for trials with a published cap, below the 786-participant average among 679 other Depression trials with a reported enrollment target (83% lower).
The record links to 7 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Park prescription is the first listed.
NCT06001697 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06001697 about?
NCT06001697 is a clinical study titled "Nature and Health: How Does Lifestyle and Environment Affect Health and Wellness". The purpose of this study is to examine if and how implementing nature prescriptions can increase time in nature and improve health to yield an actionable understanding of the nature-health connection. It aims to explore how public green spaces can be better used to improve individual and community ...
What is the current status of trial NCT06001697?
This trial is currently completed. It is a NA study. The enrollment target is 134 participants. The study started on 2023-12-18. Estimated completion is 2025-04-23.
What conditions does trial NCT06001697 study?
This clinical trial studies the following conditions: Depression, Anxiety, Sleep, Physical Inactivity, Chronic Disease.
What interventions are being tested in trial NCT06001697?
The interventions under investigation include: Park prescription (BEHAVIORAL), Regular health advice (BEHAVIORAL).
Who is sponsoring clinical trial NCT06001697?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06001697 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06001697's enrollment target sits among peer trials
134 278th of 679 higher than 400 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02469662 · 134 participants · NA
Clinical Outcomes Study of the Nexel Total Elbow
- NCT03110822 · 134 participants · Phase 1
A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients
- NCT04678648 · 134 participants · Phase 1
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
- NCT05264857 · 134 participants · NA
Decision Aid and Thyroid Nodules Management
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy